Search

everythinglearnresearchcommunity

for

Search:↓

Plant-based remedies may treat hair loss by reducing inflammation and improving insulin resistance.

The enzyme that changes testosterone to a stronger form is mostly found in the part of the hair follicle called the dermal papilla.

Spironolactone may cause sexual pain and arousal issues in women, which can improve after stopping the drug and using hormone cream.

Oral contraceptives help treat hyperandrogenic disorders, improving symptoms like excessive hair and acne.

AKR1C3 could be a treatment target for metabolic issues in PCOS.

Nanomaterials can improve hair care products and treatments, including hair loss and alopecia, by enhancing stability and safety, and allowing controlled release of compounds, but their safety in cosmetics needs more understanding.

Fluridil safely promotes hair growth in men with androgenetic alopecia.

Ketoconazole shampoo improves hair growth and reduces oil similarly to minoxidil in male pattern hair loss.

Male-pattern baldness might be caused by the effect of hormones on scalp blood vessels.

The document explains different hair loss types and treatments, emphasizing diagnosis through examination and tests, and specific treatments for each condition.

Flibanserin's effectiveness for low sexual desire in premenopausal women may vary based on hormone levels, with normal hormone levels showing better responses.

New steroids were effective in blocking male hormone receptors in hamster prostates.

New compounds were made and tested, with compound 6 showing potential for treating prostate-related diseases.

A new compound with strong antiandrogenic effects was found, potentially useful for treating conditions like acne and prostate cancer.

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.

A new topical treatment for hair loss shows strong hair growth effects with low toxicity.

New A-homo-B, 19-dinor steroids showed strong antiandrogenic activity without affecting the enzyme 5α-reductase or androgen receptor binding.

The more lipophilic the progesterone derivative, the better it binds to androgen receptors and has antiandrogenic effects.

New compounds were made that effectively block a specific enzyme related to androgen conditions.

Certain derivatives are more effective 5α-reductase type 2 inhibitors than finasteride.

Some synthesized compounds were more effective than Finasteride in reducing prostate cancer cell growth and androgen levels.

New compounds were made that are promising for prostate cancer therapy.

CB-03-04 shows promise as a treatment for prostate issues due to its strong anti-androgen effects.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

Some new progesterone derivatives are better at blocking testosterone conversion than a common drug.